Lorillard
Topical Report NCI / S&Hp / Ornl Number 67 Site Visit I to the Hazleton Laboratories Cofactor Inhalation Bioassay Rest on, Virginia, 780223
Fields
- Author
- Gill, B.E.
- Jenkins, R.A.
- Alias
- 89737834/89737844
- Type
- SCRT, SCIENTIFIC REPORT
- CHAR, CHART/GRAPH/MAPS
- TRIP, TRIP REPORT
- CHAR, CHART/GRAPH/MAPS
- Area
- SPEARS,ALEXANDER/EXEC CONF ROOM STO
- Site
- G65
- Named Organization
- NIH, Natl Inst of Health
- Oak Ridge Natl Lab
- Enviro, Enviro Control
- Erda
- Hazleton, Hazleton Labs
- NCI, Natl Cancer Inst
- Oak Ridge Natl Lab
- Master ID
- 89737566/7894
Related Documents:- 89737566-7894 Annual Report Collection, Separation, and Elucidation of the Components of Cigarette Smoke and Cigarette Smoke Condensate Part I. Chemical Characterization of Experimental Cigarette Smokes Part II. Inhalation Bioassay Monitoring and Support Part III. Dosimetry and Bioimpact
- 89737577-7588 I. Chemical Characterization of Tobacco Smoke From Beagle Dog Inhalation Exposure Systems
- 89737589 II. Final Data - Series IV Cigarette Smoke and Condensate Chemical Analyses
- 89737590-7599 Topical Report NCI / S&Hp / Ornl Number 52 Final Smoke and Condensate Data for the Fourth Series of Experimental Varia Nts
- 89737600-7602 III. Chemical Analysis of Smokes of Foreign and Domestic Commercial Cigarettes
- 89737603-7606 Topical Report NCI / S&Hp / Ornl Number 49 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737607-7610 Topical Report NCI / S&Hp / Ornl Number 61 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737611-7614 Topical Report NCI / S&Hp / Ornl Number 66 Tar, Nicotine, Co and Co2 Deliveries of Italian Cigarettes
- 89737615-7621 Topical Report NCI / S&Hp / Ornl Number 51-A Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737622-7624 Topical Report NCI / S&Hp / Ornl Number 53 Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737625-7632 Topical Report NCI / S&Hp / Ornl Number 68 Chemical Analysis of Smoke From Selected South Florida Variants
- 89737633-7647 Topical Report NCI / S&Hp / Ornl Number 70 Chemical Analyses of Smoke From Selected Foreign Cigarettes United Kingdom, Uk Export, and Developing Nations
- 89737648-7649 IV. Swri Baboon Study Smoking Extremes Experiment
- 89737650-7655 Topical Report NCI / S&Hp / Ornl Number 58 Chemical Analysis of Smoke Delivered by Swri Baboon Study Cigarette Under Three Smoking Conditions
- 89737656-7661 V. Statistical Modeling of Histopathological Probabilities
- 89737669-7682 I. Monitoring of the Chronic Inhalation Exposures
- 89737683-7698 Topical Report NCI / S&Hp / Ornl Number 41 Site Visit I to Battelle Pacific Northwest Laboratories Rat Model Inhalatio N Bioassay Richland, Washington, 770223 - 770224
- 89737699-7714 Topical Report NCI / S&Hp / Ornl Number 44 Site Visit Vi to Veteran's Administration Hospital East Orange, New Jersey, 770502 - 770503
- 89737715-7729 Topical Report NCI / S&Hp / Ornl Number 46 Site Visit IV to Hazleton Laboratory Reston, Virginia, 770521 - 770522
- 89737730-7748 Topical Report NCI / S&Hp / Ornl Number 48 Site Visit I to Enviro Control Inc. Inhalation Laboratories Temple Hills, M Aryland, 770523 - 770525
- 89737749-7760 Topical Report NCI / S&Hp / Ornl Number 54 Site Visit Vii to Veteran's Administration Hospital East Orange, New Jersey, 770808 - 770809
- 89737761-7768 Topical Report NCI / S&Hp / Ornl Number 55 Intercomparison of Tobacco Smoke Dose Beagle Dog Inhalation Bioassays
- 89737769-7777 Topical Report NCI / S&Hp / Ornl Number 59 Inhalation Bioassay of Tobacco Smoke in Pigeons Site Visit I to Beth Israel Hospital (Bih) Boston Massachusetts, 771130 - 771201
- 89737778-7798 Topical Report NCI / S&Hp / Ornl Number 60 Site Visit II to Battelle Pacific Northwest Laboratories Rat Model Inhalati on Bioassay Richland, Washington, 770914 - 770915
- 89737799-7817 Topical Report NCI / S&Hp / Ornl Number 62 Site Visit II to Borriston Research Laboratories Temple Hills, Maryland, 77 1107 - 771109
- 89737818-7833 Topical Report NCI / S&Hp / Ornl Number 64 Site Visit V to Hazleton Laboratories Reston, Virginia, 771105 - 771106
- 89737845-7856 II. Instrumental Approaches to Bioassay Monitoring
- 89737857-7858 III. Trapping and Determination of Organic Gas Phase Constituents of Cigarette Smoke
- 89737859-7862 Trapping and Determination of Labile Compounds in the Gas Phase of Cigarette Smoke
- 89737863-7865 IV. Determination of Nitric Oxide and Nitrogen Dioxide in Cigarette Smoke by Chemiluminescent Analysis
- 89737868-7869 I. Brl - Ornl Collaborative Smoke Particulate Deposition Experiment
- 89737870-7876 II. C Tracer Studies to Develop Sampling Protocols for Quantitative Nicotine Dosimetry Following Smoke Exposure
- 89737877-7884 III. Isolation and Quantitative Analysis of Nicotine and Cotinine in Physiological Fluids
- 89737885-7894 IV. Physiological Fluids Studies: Mutagenicity and Profiling
- Named Person
- Coate, W.B.
- Jenkins, R.A.
- Nightingale, T.
- Jenkins, R.A.
- Date Loaded
- 12 Feb 1999
- Author (Organization)
- Analytical Chemistry Division
- Bio Organic Analysis Section
- NCI, Natl Cancer Inst
- Oak Ridge Natl Lab
- Bio Organic Analysis Section
- Litigation
- Stmn/Produced
- Characteristic
- ATCH, ATTACHMENTS MISSING
- CONF, CONFIDENTIAL
- EXTR, EXTRA
- CONF, CONFIDENTIAL
- Brand
- 13
- 23
- UCSF Legacy ID
- dod30e00
Document Images
Topical Report
NCI/S&HP/ORNL #67
SITE VISIT I TO THE HAZLETON LABORATORIES
COFACTOR INHALTION BIOASSAY
Reston, Virginia, February 23, 1978
3-16-7£3
R. A. Jenkins and B. E. Gill
Tobacco Smoke Research Program
Bio/Organic Analysis Section
Analytical Chemistry Division
Oak Ridge National Laboratory
Oak Ridge, Tennessee 37830
Interagency Agreement (ERDA-PdIFf/NCI) No. 40-485-74, Part II
Internal (aRNL) Contract Charge No. 3390-0224
Intended for informal communication with project management only.
Confidential until published or released by author.

SITE VISIT I TO THE HAZLETON LABORATORIES
COFACTOR INHALATION BIOASSAY ,
R: A. Jenkins and B. E. Gi1l
Summary. A first visit was made to the new tobacco smoke-cofactor inhal-
ation bioassay at Hazleton Laboratories to assess the relative importance
of the contribution of several factors to any potential variation in carbon
monoxide dose in the animal exposure groups. The data obtained on that
visit indicate that the added gas delivery systems of the smoke exposure
machines perform very reproducibly and cannot be a significant source of
variation in carbon monoxide dose. The most important contribution to the
small variation that is noted is the number of puffs required to consume a
given cigarette to a 23-mm butt length. This value will undergo normal
cigarette-to-cigarette variation, and without expensive weight and resistance-
to-draw selection of cigarettes, cannot be tightly controlled. In order to
reduce the small difference in CO dose between the two cofactor addition ex-
posure groups, it was recommended that the per-puff added gas delivery of
the Code 23 exposure systems be slightly reduced.
Introduction. At the request of NCI Smoking and Health Program management,
ORNL staff visited the tobacco smoke-cofactor inhalation bioassay being con-
ducted at Hazleton Laboratories (HL) on February 23, 1978. The primary ob-
jective of this visit was to assess the magnitude of the cofactor (carbon
monoxide) dose which the animal groups would be offered, and determine the
extent and source of any variability in that dose.
Experimental. This is a new inhalation study. It involves the chronic ex-
posure of male beagle dogs to whole cigarette smoke and smoke enriched with
carbon monoxide (CO). For the cofactor studies, the smoke exposure system
being employed is the ADL/II-cuffed cannula system modified with an external
gas delivery system. The ADL/II has been affixed with a valve whose operation
has been synchronized to the travel of the smoking machine's sliding cylinder.
The cofactor gas (,ti20'% CO in nitrogen) is metered through an adjustable needle
valve, and into a needle which penetrates a small piece of rubber tubing be-
tween , .
tween the outlet of the ADL/II and a glass bulb attached to the head of the
system stand tube. Constancy of the flow of added gas is ensured by (1)
i

constant pressure at the second stage of a two-stage regulator on the gas
supply tank and (2) constancy of restriction of the met.ering needle valve.
As the sliding cylinder reverses its_direction, the metering valve shuts
off, and the gas aliquot enters the bulb at the head of the stand tube
fractions of a second before the smoke enters. The animal then inhales the
smoke-gas bolus as he would normal cigarette smoke.
Most experimental details and procedures have been described previously,
and can be found in reports covering earlier visits to HL (Topical Reports
NCI/S&HP/ORNL #24, 29, 33, 36A, 46, 64). A soap bubble displacement meter
was used to measure the volume of added cofactor gas. The needle was removed
from the stand tube of the ADL/II and inserted into a tube connected to the
meter. The volume displaced by the bolus was noted and recorded.
Results and Discussion. The dose of carbon monoxide, per cigarette, which
the animals exposed to smoke plus CO are offered is a function of four dis-
tinct factors:
1. Concentration of carbon monoxide in the added gas. This is
constant, assuming the integrity of the supply tank is main-
tained.
2. The volume, per puff, of the added gas, which may or may not
vary among individual exposure systems.
3. The length of time of exposure to the added gas. This is
directly proportional to the amount of time the machine is
operating, which, in turn, is a function of the number of
puffs which the cigarette is smoked.
4. The amount of carbon monoxide in the smoke of the cigarette
itself. This is subject to normal cigarette-to-cigarette
variability.
An attempt was made on this site visit to assess the variability of these
factors. The results of the assessment are discussed below.
The volumes of gas added, per puff, for selected machines are tabulated
and compared on Table I. Clearly, the amount of added gas delivered to the
ADL/II stand tube is highly reproducible* from machine to machine. The relative
standard deviations for each +code are less than 4%. The absolute magnitude
of the de1 i very i s about 20 ml per puff, about 7 3% hi gher than the targeted

addition of 17.5 ml per puff. The difference is probably due to the use
of a syringe barrel displacement procedure at Hazleton to determine gas
addition volume. There may be a resistance to displacement of the syringe
barrel which would increase the pressure of the gas in the syringe. The
17.5 ml displaced volume measured with the syringe at slightly elevated
pressure might be equivalent to a volume of 20 ml at ambient pressure. In
summary, while the amount of cofactor gas may be slightly greater than that
targeted, the machine-to-machine variation in this gas volume is so small
that it cannot be responsible for offered dose variation or for differences
in the carboxyhemoglobin levels among animals in a given exposure group.
The TPM and nicotine deliveries of cigarettes smoked on ADLJII's at
Hazleton are compared on Table II with those of cigarettes from the same
batch returned to ORNL and smoked under analytical conditions. Interest-
ingly, the Code 23 variant produced more nicotine but less TPM at the HL
than under analytical conditions. The carbon monoxide deliveries under
analytical conditions are very similar to those determined previously under
the same conditions (see letter to E4. B. Coate from R. A. Jenkins, July 26,
1977, attached), suggesting that no gross differences exist between the
original control cigarettes and those sampled from the bioassay.
The amounts of CO, nicotine, TPM and C02 delivered to the cannula under
both normal smoking and cofactor addition protocols are presented on Tables
III and IV for the Code 13 and 23 exposure groups, respectively. In addi-
tion, amounts of CO presumed to have been added for each machine-cigarette
combination are also presented. Several important points should be noted.
First, the amounts of TPM, nicotine, and C02 delivered to the cannula for a
given cigarette variant are essentially the same under both normal smoking
and cofactor addition conditions. This suggests that both types of machines
(cofactor and normal) are smoking cigarettes in a similar manner. Secondly,
the amounts of carbon monoxide delivered to the cannula under normal smoking
conditions are the same for both codes. This similarity has been noted
previously (see text of attached letter) for CO delivery on the ADLJII, but
the magnitude of the delivery was signifiecantly different. Presumably, both
types of cigarettes generate'COrwhich is delivered in equal amounts to the
cannula under cofactor addition conditions also.

The final point is the most important. From the data on Tables III and
IV, it is clear that there is quite a bit of variation in the amount of CO
calculated to have been added for each machine-cigarette combination. This
calculated value is a product of (a) the concentration of carbon monoxide in
the cofactor gas (20.3%), (b) the volume of gas added per puff for each in-
dividual machine (see Table I), and (c) the number of puffs taken to consume
each cigarette. Since (a) and (b) are virtually constant, clearly the greatest
contribution to variation in the amount of added CO for each individual
machine-cigarette combination is the number of puffs required to smoke the
cigarette. As is evident from Tables III and IV, this puff number can vary
greatly even within a given variant code. In addition, the amount of added
carbon monoxide appears to be greater for the Code 23 group than for the Code
13 group. This is due to the differences between the two variants in the
number of puffs required to smoke the cigarette to a 23-mm butt length.
A summary of the per-cigarette offered doses for two of the more important
smoke constituents is made on Table V. Ideally, the amount of carbon monoxide
offered the animals receiving the added gas dose should be the sum of the ciga-
rette CO contribution and the amount of CO calculated to have been delivered to
the exposure system. For the Code 23 group, the sum of the average deliveries
16.0 + 59.4 = 75.4 ml CO/cigarette) compares well with that which was observed
at the cannula (76.7 ml/cigarette). For the Code 13 group, the anticipated
dose (66.7 ml,Ocigarette) also compares well with the observed dose (67.2
ml/cigarette).
The ratios of the carbon monoxide dose for the cofactor addition group
to that of the normal smoking group are 4.4:1 for the Code 13 variant and
4.8:1 for the Code 23 variant. Both of these ratios are substantially greater
than the targeted value of 3:1, primarily for two reasons. First, the added
gas delivery measuring system in use at I-fL permits a slightly greater amount
of CO to be added for each puff. Secondly, both variant codes do not deliver
as much carbon monoxide to the cannula as was anticipated from analytical
smoking or exposure system sm®king at ORNL (see attached letter). Again,
the primary reason for the CO dose differences between the two cofactor addi-
tion groups is the difference'in the puff numbers of the two variants.
Recommendation. The preceding information was reviewed by phone with Dr.
W. Coate of Hazleton and Dr. T. Nightingale of Enviro Control, Inc. Based
on those discussions, the following recommendations were made:

In an attempt to overcome differences in CO dose for the two cofactor
addition groups, the per puff delivery of carbon monoxide should be slightly
reduced for machines used to smoke the Code 23 cigarettes, such that the
total added CO delivery over the greater number of puffs of the Code 23 var-
iant will be equal to that of the machines smoking the Code 13 cigarettes
in a fewer number of puffs. No other changes in the smoking or exposure
protocol should be made. In addition, a more accurate measurement system
for added gas delivery volumes, such as a soap bubble meter, should be used
by Hazleton.

TABLE I
Per-Puff Machine°Gas Addition Volumes*
Cofactor Addition Machines
Cigar
Co ette
de Machine No. Added Gas
Vo1ume, ml/puff
13 34 19.6
28 19.9
40 19.4
14 20.3
12 20.3
39 20.0
Average 19.9 ± 0.4
23 25 19.9 I
5 20.0
10 19.4
9 18.5
1 20.6
19 19.5
Average 19.7 ± 0.7
*"Gas" added is a portion of a standard which is
20.3% CO in nitrogen.

TABLE II
Comparison of Cigarette Deliveries: Input to ADL/II at HL
vs Analytical Smoking Machine at ORNLa
Site Visit C-I
Cigarette TPM Nicotine C0, C02
Machi ne Code # Puffs mg/ci g mg/ci ~ m1 /ci g ml Jci g
ADL/II 13 12.7 t 0.8 38.2 ± 6.4 0.19 ± 0.03 b b
Analytical 13 11.5 ± 0.5 43.7 ± 0.5 0.23 ± 0.02 24.4 ± 0.7 47.9 ± 2.2
ADL/II 23 14.8 ± 1.5 44.7 ± 6.0 2.62 ± 0.18 b b
,
Analytical 23 16.4 ± 0.3 53.3 ± 0.8 2.20 ± 0.04 30.6 ± 0.6 65.6 ± 1.1
I
aCigarettes smoked on Phipps and Bird analytical smoking machine, at 2 puffs per minute,
eight cigarettes per code.
bInput deliveries of CO and C02 for cigarettes smoked on ADL/II are not conveniently
obtainable. However, since little loss of permanent gases occur within machine,
outputs of CO/CO2 for each cigarette code (from Tables III and IV) can be compared
with the analytical values on this table.
r084£&68

TABLE III
Cannula Exit Deliveries
ADL/II Systems Smoking Code 13 Cigarettes
Machine No.
# Puffs
TPM,
mg/cig
Nicotine,
mg/ciq
C0,
ml/cig Calculated
C02 Amount of
ml/cig Added C0, ml
~s 16 14 23.9 0.15 15 35
/" 17 15 23.6 0.14 14 37
Normal / 24 13 25.9 0.12 15 36
Smoking 32 14 28.2 0.18 20 41
3 11 23.8 0.16 13 29
'Average 13.4 ± 1.5 25.1 ± 2.0 0.15 ± 0.03 15.4 ± 2.7 35.6 ± 4.3
34 16 25.0 0.17 74 35 63.7
28' 13 25.0 0.22 68 31 52.5
Smoking with 40`
I 12 20.5 0.14 62 31 47.3
Added Carbon 14 11 23.4 0.14 62 33 45.3
Monoxide 12 11 22.1 0.14 69 32 45.3
39 13 23.1 0.17 68 30 52.8
Average 12.7 t 1.9 23.2 ± 1.7 0.16 ± 0.03 67.2 ± 4.6 32.0 ± 1.8 51.2 ± 7.0
i
Z ~'q4E&fiB

TABLE IV
Cannula Exit Deliveries
ADL/II Systems Smoking Code 23 Cigarettes
TPM,
Nicotine,
C0,
C02 Calculated
Amount of
Machine No. # Puffs mq/cig mg/cig ml/cig ml/ciq Added C0, ml
26 15 31.2 1.95 16 42
38 16 33.5 1.99 17 44
Normal 30 16 35.6 2.11 20 47
Smoking 36 13 24.6 1.49 12 36
37 13 27.1 1.59 15 36
6 14 28.1 1.53 16 39
Average 14.5-F 1.4 30.0 ± 4.2 1.78 ± 0.27 16.0 ± 2.6 40.7 ± 4.5
2 5 15 31.7 1.90 81 44 60.6
5~ 15 28.2 1.53 76 37 60.9
Smoking with 10 16 29.6 1.88 80 36 63.0
Added Carbon 9 12 19.1 1.69 64 26 45.1
Monoxide 1 17 37.1 1.47 85 35 71.1
19 14 29.5 1.76 74 37 55.4
Average 14.8 ± 1.7 29.2 ± 5.9 1.71 ± 0.18 76.7 ± 7.3 35.8 ± 5.8 59.4 ± 8.6
EVs4=9
